FAST NEWS: Everest Medicines Hits New Low after New CEO Announcement
The latest: Innovative drug maker Everest Medicines Ltd. (1952.HK) on Monday announced the appointment of Luo Yongqing, formerly president and general manager of Greater China for Brii Biosciences Ltd. (2137.HK),…
Everest Boosts Covid Bet With New Licensing Deal Despite Crowded Field
Global agreement for oral anti-viral comes just months after company signed separate similar tie-up for a Covid mRNA vaccine also in development Key Takeaways Everest has signed a global licensing…
FAST NEWS: Biotech Startup Sciwind Lands $70 Million in New Funding
The latest: Biotech startup Hangzhou Sciwind Biosciences Co. Ltd. announced it has closed its third funding round, raising 450 million yuan ($70 million). New backers in the latest round included…
RELATED ARTICLES
-
Everest Medicines drives growth with AI-powered mRNA pipeline
1952.HK -
Everest gets boost from core product Nefecon’s inclusion in China’s national health plan
1952.HK
-
BRIEF: Everest unveils positive results for kidney drug EVER001 in Phase 1b/2a trial
1952.HK
-
NEWS WRAP: DouYu names new CEO, declares massive dividend to entice investors
DOYU.US
- As Covid drug cash dwindles, Vigonvita targets new remedies
